A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Testing of hemoglobin A 1C (HbA 1C ) levels has become widespread in the management of patients with diabetes mellitus. Since the 1980s, it has proven to be an invaluable tool correlating with a patient's average blood glucose levels as well as with their disease morbidity. Clinicians often base treatment decisions and make adjustments depending on a patient's HbA 1C level. As useful as the HbA 1C is, it does have notable limitations. A number of conditions can lead to a falsely elevated or adoi:10.3122/jabfm.2007.01.060086 pmid:17204741 fatcat:q4k5dpekobbglknwxmdcueoopi